In conclusion, our study conducted within real-world clinical settings revealed a noteworthy association between the use of GLP-1 RAs, including Liraglutide and Semaglutide, and a heightened risk of psychiatric outcomes, encompassing depression, anxiety, and suicidal behaviour
Its self-efficacy and robust weight loss outcomes, and other health benefits beyond weight loss, are reaching the peak of good and long-life advice to individuals and dieticians, or weight loss experts
As the connection between GLP-1 therapy and fatigue unfolds, it becomes essential to explore effective strategies for managing tiredness and enhancing overall well-being during this journey
Malhotra, A., Grunstein, R
Tamura et al., 2010)
This not only supports GLP-1 secretion but also enhances satiety, helping to curb cravings and promote a balanced diet